|
1
|
Beehler GP, Sekhon M, Baker JA, Teter BE,
McCann SE, Rodabaugh KJ and Moysich KB: Risk of ovarian cancer
associated with BMI varies by menopausal status. J Nutr.
136:2881–2886. 2006.PubMed/NCBI
|
|
2
|
Olsen CM, Green AC, Whiteman DC, Sadeghi
S, Kolahdooz F and Webb PM: Obesity and the risk of epithelial
ovarian cancer: a systematic review and meta-analysis. Eur J
Cancer. 43:690–709. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ioka A, Tsukuma H, Ajiki W and Oshima A:
Ovarian cancer incidence and survival by histologic type in Osaka,
Japan. Cancer Sci. 94:292–296. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bray GA: The underlying basis for obesity:
relationship to cancer. J Nutr. 132:3451S–3455S. 2002.PubMed/NCBI
|
|
5
|
Leitzmann MF, Koebnick C, Danforth KN,
Brinton LA, Moore SC, Hollenbeck AR, Schatzkin A and Lacey JV Jr:
Body mass index and risk of ovarian cancer. Cancer. 115:812–822.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schouten LJ, Rivera C, Hunter DJ,
Spiegelman D, Adami HO, Arslan A, Beeson WL, van den Brandt PA,
Buring JE, Folsom AR, Fraser GE, Freudenheim JL, Goldbohm RA,
Hankinson SE, Lacey JV Jr, Leitzmann M, Lukanova A, Marshall JR,
Miller AB, Patel AV, Rodriguez C, Rohan TE, Ross JA, Wolk A, Zhang
SM and Smith-Warner SA: Height, body mass index, and ovarian
cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol
Biomarkers Prev. 17:902–912. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Calle EE, Rodriguez C, Walker-Thurmond K
and Thun MJ: Overweight, obesity, and mortality from cancer in a
prospectively studied cohort of U.S. adults. N Engl J Med.
348:1625–1638. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rodriguez C, Jacobs EJ, Patel AV, Calle
EE, Feigelson HS, Fakhrabadi-Shokoohi D and Thun MJ: Jewish
ethnicity and prostate cancer mortality in two large US cohorts.
Cancer Causes Control. 13:271–277. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pavelka JC, Brown RS, Karlan BY, Cass I,
Leuchter RS, Lagasse LD and Li AJ: Effect of obesity on survival in
epithelial ovarian cancer. Cancer. 107:1520–1524. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Key T, Appleby P, Barnes I and Reeves G;
Endogenous Hormones and Breast Cancer Collaborative Group:
Endogenous sex hormones and breast cancer in postmenopausal women:
reanalysis of nine prospective studies. J Natl Cancer Inst.
94:606–616. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Risch HA: Hormonal etiology of epithelial
ovarian cancer, with a hypothesis concerning the role of androgens
and progesterone. J Natl Cancer Inst. 90:1774–1786. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hu X, Juneja SC, Maihle NJ and Cleary MP:
Leptin - a growth factor in normal and malignant breast cells and
for normal mammary gland development. J Natl Cancer Inst.
94:1704–1711. 2002. View Article : Google Scholar
|
|
13
|
Chen C, Chang YC, Liu CL, Chang KJ and Guo
IC: Leptin-induced growth of human ZR-75-1 breast cancer cells is
associated with up-regulation of cyclin D1 and c-Myc and
down-regulation of tumor suppressor p53 and p21WAF1/CIP1. Breast
Cancer Res Treat. 98:121–132. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sharma D, Saxena NK, Vertino PM and Anania
FA: Leptin promotes the proliferative response and invasiveness in
human endometrial cancer cells by activating multiple
signal-transduction pathways. Endocr Relat Cancer. 13:629–640.
2006. View Article : Google Scholar
|
|
15
|
Somasundar P, Frankenberry KA, Skinner H,
Vedula G, McFadden DW, Riggs D, Jackson B, Vangilder R, Hileman SM
and Vona-Davis LC: Prostate cancer cell proliferation is influenced
by leptin. J Surg Res. 118:71–82. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Uddin S, Bu R, Ahmed M, Abubaker J,
Al-Dayel F, Bavi P and Al-Kuraya KS: Overexpression of leptin
receptor predicts an unfavorable outcome in Middle Eastern ovarian
cancer. Mol Cancer. 8:742009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Garofalo C and Surmacz E: Leptin and
cancer. J Cell Physiol. 207:12–22. 2006. View Article : Google Scholar
|
|
18
|
Chen C, Chang YC, Liu CL, Liu TP, Chang KJ
and Guo IC: Leptin induces proliferation and anti-apoptosis in
human hepatocarcinoma cells by up-regulating cyclin D1 and
down-regulating Bax via a Janus kinase 2-linked pathway. Endocr
Relat Cancer. 14:513–529. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Choi JH, Park SH, Leung PC and Choi KC:
Expression of leptin receptors and potential effects of leptin on
the cell growth and activation of mitogen-activated protein kinases
in ovarian cancer cells. J Clin Endocrinol Metab. 90:207–210. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Buettner R, Mora LB and Jove R: Activated
STAT signaling in human tumors provides novel molecular targets for
therapeutic intervention. Clin Cancer Res. 8:945–954.
2002.PubMed/NCBI
|
|
21
|
Heiser D, Labi V, Erlacher M and Villunger
A: The Bcl-2 protein family and its role in the development of
neoplastic disease. Exp Gerontol. 39:1125–1135. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Reynolds JE, Yang T, Qian L, Jenkinson JD,
Zhou P, Eastman A and Craig RW: Mcl-1, a member of the Bcl-2
family, delays apoptosis induced by c-Myc overexpression in Chinese
hamster ovary cells. Cancer Res. 54:6348–6352. 1994.PubMed/NCBI
|
|
23
|
Michels J, Johnson PW and Packham G:
Mcl-1. Int J Biochem Cell Biol. 37:267–271. 2005. View Article : Google Scholar
|
|
24
|
Shigemasa K, Katoh O, Shiroyama Y, Mihara
S, Mukai K, Nagai N and Ohama K: Increased MCL-1 expression is
associated with poor prognosis in ovarian carcinomas. Jpn J Cancer
Res. 93:542–550. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kuo ML, Chuang SE, Lin MT and Yang SY: The
involvement of PI 3-K/Akt-dependent up-regulation of Mcl-1 in the
prevention of apoptosis of Hep3B cells by interleukin-6. Oncogene.
20:677–685. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Leu CM, Chang C and Hu C: Epidermal growth
factor (EGF) suppresses staurosporine-induced apoptosis by inducing
mcl-1 via the mitogen-activated protein kinase pathway. Oncogene.
19:1665–1675. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wei LH, Kuo ML, Chen CA, Chou CH, Cheng
WF, Chang MC, Su JL and Hsieh CY: The anti-apoptotic role of
interleukin-6 in human cervical cancer is mediated by up-regulation
of Mcl-1 through a PI 3-K/Akt pathway. Oncogene. 20:5799–5809.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rouet-Benzineb P, Aparicio T, Guilmeau S,
Pouzet C, Descatoire V, Buyse M and Bado A: Leptin counteracts
sodium butyrate-induced apoptosis in human colon cancer HT-29 cells
via NF-κB signaling. J Biol Chem. 279:16495–16502. 2004.PubMed/NCBI
|
|
29
|
Nicholson DW, Ali A, Thornberry NA,
Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle
M, Lazebnik YA, et al: Identification and inhibition of the
ICE/CED-3 protease necessary for mammalian apoptosis. Nature.
376:37–43. 1995. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Germain M, Affar EB, D’Amours D, Dixit VM,
Salvesen GS and Poirier GG: Cleavage of automodified
poly(ADP-ribose) polymerase during apoptosis. Evidence for
involvement of caspase-7. J Biol Chem. 274:28379–28384. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Knudsen KE, Diehl JA, Haiman CA and
Knudsen ES: Cyclin D1: polymorphism, aberrant splicing and cancer
risk. Oncogene. 25:1620–1628. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang JM, Chao JR, Chen W, Kuo ML, Yen JJ
and Yang-Yen HF: The antiapoptotic gene mcl-1 is up-regulated by
the phosphatidylinositol 3-kinase/Akt signaling pathway through a
transcription factor complex containing CREB. Mol Cell Biol.
19:6195–6206. 1999.PubMed/NCBI
|
|
33
|
Ogden CL, Carroll MD, Kit BK and Flegal
KM: Prevalence of obesity in the United States, 2009–2010. NCHS
Data Brief. 1–8. 2012.
|
|
34
|
Flegal KM, Carroll MD, Kit BK and Ogden
CL: Prevalence of obesity and trends in the distribution of body
mass index among US adults, 1999–2010. JAMA. 307:491–497. 2012.
|
|
35
|
Bray GA: Drug treatment of obesity. Rev
Endocr Metab Disord. 2:403–418. 2001. View Article : Google Scholar
|
|
36
|
Simonin K, Brotin E, Dufort S, Dutoit S,
Goux D, N’Diaye M, Denoyelle C, Gauduchon P and Poulain L: Mcl-1 is
an important determinant of the apoptotic response to the
BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian
carcinoma cells. Mol Cancer Ther. 8:3162–3170. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Varin E, Denoyelle C, Brotin E,
Meryet-Figuière M, Giffard F, Abeilard E, Goux D, Gauduchon P,
Icard P and Poulain L: Downregulation of Bcl-xL and Mcl-1 is
sufficient to induce cell death in mesothelioma cells highly
refractory to conventional chemotherapy. Carcinogenesis.
31:984–993. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Brotin E, Meryet-Figuière M, Simonin K,
Duval RE, Villedieu M, Leroy-Dudal J, Saison-Behmoaras E, Gauduchon
P, Denoyelle C and Poulain L: Bcl-XL and MCL-1 constitute pertinent
targets in ovarian carcinoma and their concomitant inhibition is
sufficient to induce apoptosis. Int J Cancer. 126:885–895.
2010.PubMed/NCBI
|
|
39
|
Weng C, Li Y, Xu D, Shi Y and Tang H:
Specific cleavage of Mcl-1 by caspase-3 in tumor necrosis
factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis
in Jurkat leukemia T cells. J Biol Chem. 280:10491–10500. 2005.
View Article : Google Scholar : PubMed/NCBI
|
